This new information can potentially improve our understanding of the molecular mechanisms involved in hypertension pathogenesis and foster the development of therapeutic solutions for hypertension-related diseases, furthermore, helping to establish IL-1β as a valid target for hypertension. This evidence concerns the gene IL1B and hypertensive disorder.